Roche Holding AG (ROG.VX)

ROG.VX on Virt-X Level 1

265.70CHF
11:19am EDT
Price Change (% chg)

CHF-1.00 (-0.37%)
Prev Close
CHF266.70
Open
CHF266.00
Day's High
CHF268.00
Day's Low
CHF264.40
Volume
879,530
Avg. Vol
1,088,231
52-wk High
CHF274.80
52-wk Low
CHF226.30

ROG.VX

Chart for ROG.VX

About

Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to... (more)

Overall

Beta: 0.87
Market Cap (Mil.): CHF229,173.50
Shares Outstanding (Mil.): 862.56
Dividend: 7.80
Yield (%): 2.92

Financials

  ROG.VX Industry Sector
P/E (TTM): 21.39 35.82 36.29
EPS (TTM): 12.47 -- --
ROI: 26.39 18.85 18.13
ROE: 68.57 19.57 18.95
Search Stocks

AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests

LONDON - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.

28 Jul 2014

AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests

LONDON, July 28 - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.

28 Jul 2014

Roche's breast cancer drugs keep it on track to meet targets

BASEL - Swiss drugmaker Roche confirmed its full-year sales and profit targets on Thursday as growing momentum for its new breast cancer medicines and professional diagnostics products countered the effects of a strong Swiss franc.

24 Jul 2014

UPDATE 2-Roche's breast cancer drugs keep it on track to meet targets

* Shares rise 2.1 percent in early trade (Adds details, analyst, shares)

24 Jul 2014

Roche shares rise 1.3 pct after H1 results

ZURICH, July 24 - Roche shares rose 1.3 percent at the open on Thursday after publishing H1 results. (Reporting by Joshua Franklin)

24 Jul 2014

BRIEF-Roche CEO-"too early" to make a decision on crenezumab

July 24 - Roche Holding AG : * CEO says "too early" to make a decision on whether to take alzheimer's drug

24 Jul 2014

Roche first half net profit hit by diagnostics writedown

BASEL, July 24 - Swiss drugmaker Roche posted weaker-than-expected net profit for the first half, hit by a writedown on its tissue diagnostics business.

24 Jul 2014

European shares bounce back, helped by earnings reports

* Ukraine rebels hand over black boxes from Malaysian plane

22 Jul 2014

European shares bounce back as Ukraine tension ease

* Ukraine rebels hand over black boxes from Malaysian plane

22 Jul 2014

European shares up as Ukraine rebels allow improved access

* Ukraine rebels hand over black boxes from Malaysian plane

22 Jul 2014

Earnings vs. Estimates

Search Stocks